Annual Operating Expenses
$121.41 M
+$9.32 M+8.31%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual total operating expenses is currently $121.41 million, with the most recent change of +$9.32 million (+8.31%) on 31 December 2023. During the last 3 years, it has risen by +$70.90 million (+140.36%). TNXP annual operating expenses is now at all-time high.TNXP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$15.15 M
-$2.05 M-11.90%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly total operating expenses is currently $15.15 million, with the most recent change of -$2.05 million (-11.90%) on 30 September 2024. Over the past year, it has dropped by -$14.61 million (-49.09%). TNXP quarterly operating expenses is now -55.30% below its all-time high of $33.90 million, reached on 31 March 2023.TNXP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.3% | -49.1% |
| 3 y3 years | +140.4% | -18.3% |
| 5 y5 years | +361.2% | +92.0% |
TNXP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +140.4% | -55.3% | at low |
| 5 y | 5 years | at high | +361.2% | -55.3% | +107.7% |
| alltime | all time | at high | >+9999.0% | -55.3% | >+9999.0% |
Tonix Pharmaceuticals Holding Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.15 M(-11.9%) |
| June 2024 | - | $17.20 M(-22.4%) |
| Mar 2024 | - | $22.17 M(-22.9%) |
| Dec 2023 | $121.41 M(+8.3%) | $28.74 M(-3.4%) |
| Sept 2023 | - | $29.76 M(+2.6%) |
| June 2023 | - | $29.00 M(-14.5%) |
| Mar 2023 | - | $33.90 M(+3.6%) |
| Dec 2022 | $112.09 M(+21.4%) | $32.73 M(+10.6%) |
| Sept 2022 | - | $29.59 M(+26.8%) |
| June 2022 | - | $23.34 M(-11.7%) |
| Mar 2022 | - | $26.44 M(-10.3%) |
| Dec 2021 | $92.31 M(+82.8%) | $29.48 M(+59.0%) |
| Sept 2021 | - | $18.54 M(-21.3%) |
| June 2021 | - | $23.56 M(+13.6%) |
| Mar 2021 | - | $20.74 M(+21.8%) |
| Dec 2020 | $50.51 M(+75.2%) | $17.02 M(+41.9%) |
| Sept 2020 | - | $12.00 M(-15.5%) |
| June 2020 | - | $14.19 M(+94.5%) |
| Mar 2020 | - | $7.30 M(-16.5%) |
| Dec 2019 | $28.83 M(+9.5%) | $8.73 M(+10.7%) |
| Sept 2019 | - | $7.89 M(+33.6%) |
| June 2019 | - | $5.91 M(-6.2%) |
| Mar 2019 | - | $6.30 M(-17.7%) |
| Dec 2018 | $26.32 M(+23.6%) | $7.65 M(+38.1%) |
| Sept 2018 | - | $5.54 M(-9.8%) |
| June 2018 | - | $6.14 M(-12.1%) |
| Mar 2018 | - | $6.99 M(+26.1%) |
| Dec 2017 | $21.29 M(-45.4%) | $5.54 M(-5.0%) |
| Sept 2017 | - | $5.83 M(+21.0%) |
| June 2017 | - | $4.82 M(-5.3%) |
| Mar 2017 | - | $5.09 M(-32.2%) |
| Dec 2016 | $38.97 M | $7.51 M(-1.3%) |
| Sept 2016 | - | $7.61 M(-22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | $9.84 M(-29.8%) |
| Mar 2016 | - | $14.01 M(+4.6%) |
| Dec 2015 | $48.16 M(+74.1%) | $13.40 M(+0.9%) |
| Sept 2015 | - | $13.28 M(+12.7%) |
| June 2015 | - | $11.78 M(+21.5%) |
| Mar 2015 | - | $9.70 M(+7.7%) |
| Dec 2014 | $27.66 M(+154.0%) | $9.00 M(+21.1%) |
| Sept 2014 | - | $7.43 M(+22.9%) |
| June 2014 | - | $6.05 M(+17.0%) |
| Mar 2014 | - | $5.17 M(+39.4%) |
| Dec 2013 | $10.89 M(+63.4%) | $3.71 M(+20.0%) |
| Sept 2013 | - | $3.09 M(+48.2%) |
| June 2013 | - | $2.09 M(+4.2%) |
| Mar 2013 | - | $2.00 M(+4.4%) |
| Dec 2012 | $6.66 M(+97.2%) | $1.92 M(+10.5%) |
| Sept 2012 | - | $1.73 M(-6.3%) |
| June 2012 | - | $1.85 M(+59.5%) |
| Mar 2012 | - | $1.16 M(-22.4%) |
| Dec 2011 | $3.38 M(+75.2%) | $1.49 M(+47.3%) |
| Sept 2011 | - | $1.01 M(+185.1%) |
| June 2011 | - | $355.80 K(-30.7%) |
| Mar 2011 | - | $513.70 K(-73.2%) |
| Dec 2010 | $1.93 M(>+9900.0%) | $1.92 M(>+9900.0%) |
| Sept 2010 | - | $3700.00(+54.2%) |
| June 2010 | - | $2400.00(-58.6%) |
| Mar 2010 | - | $5800.00(+65.7%) |
| Dec 2009 | $13.90 K(-0.7%) | $3500.00(+34.6%) |
| Sept 2009 | - | $2600.00(-51.9%) |
| June 2009 | - | $5400.00(+125.0%) |
| Mar 2009 | - | $2400.00(-22.6%) |
| Dec 2008 | $14.00 K | $3100.00(-13.9%) |
| Sept 2008 | - | $3600.00(-32.1%) |
| June 2008 | - | $5300.00(+165.0%) |
| Mar 2008 | - | $2000.00 |
FAQ
- What is Tonix Pharmaceuticals Holding annual total operating expenses?
- What is the all time high annual operating expenses for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual operating expenses year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly operating expenses year-on-year change?
What is Tonix Pharmaceuticals Holding annual total operating expenses?
The current annual operating expenses of TNXP is $121.41 M
What is the all time high annual operating expenses for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual total operating expenses is $121.41 M
What is Tonix Pharmaceuticals Holding annual operating expenses year-on-year change?
Over the past year, TNXP annual total operating expenses has changed by +$9.32 M (+8.31%)
What is Tonix Pharmaceuticals Holding quarterly total operating expenses?
The current quarterly operating expenses of TNXP is $15.15 M
What is the all time high quarterly operating expenses for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly total operating expenses is $33.90 M
What is Tonix Pharmaceuticals Holding quarterly operating expenses year-on-year change?
Over the past year, TNXP quarterly total operating expenses has changed by -$14.61 M (-49.09%)